JP3510751B2 - Whitening cosmetics - Google Patents
Whitening cosmeticsInfo
- Publication number
- JP3510751B2 JP3510751B2 JP33754696A JP33754696A JP3510751B2 JP 3510751 B2 JP3510751 B2 JP 3510751B2 JP 33754696 A JP33754696 A JP 33754696A JP 33754696 A JP33754696 A JP 33754696A JP 3510751 B2 JP3510751 B2 JP 3510751B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- whitening
- effect
- test
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Cosmetics (AREA)
Description
【発明の詳細な説明】
【0001】
【発明の属する技術分野】本発明は、皮膚安全性に優
れ、紫外線による皮膚の炎症を予防する効果と、黒化し
た皮膚を速やかに淡色化する効果とを持つ美白化粧料に
関する。さらに詳しくは、ニコチン酸アミドと油溶性甘
草エキスを組み合わせて用いることにより、相乗的に美
白効果が増強され、これらを含有させることにより従来
より優れた効果を持つ美白化粧料に関する。
【0002】
【従来の技術および発明が解決しようとする課題】紫外
線により皮膚は炎症(紅斑)を起こし種々の因子が放出
されメラノサイトを刺激する。これにより色調は変化し
黒化する。この黒化は、メラノサイトにおいて産生され
表皮細胞に受け渡されるメラニンの過剰生産が原因であ
り、メラニンはチロシンが酸化されて産生される。
【0003】従来より、皮膚の黒化やしみ、そばかすを
防ぎ本来の白い肌を保つために、このチロシンの酸化を
防止するビタミンCの塩や脂肪酸誘導体、さらにハイド
ロキノンモノベンジルエーテル、過酸化水素、コウジ酸
などを配合した美白化粧料が提案されている。
【0004】しかし、これらの美白化粧料中にコウジ酸
を配合した場合、紫外線による炎症抑制効果、美白効果
を充分に発揮するものではない。一方、美白化粧料中に
ハイドロキノンモノベンジルエーテルなどを配合する
と、色黒の肌を淡色化する効果はあるが、皮膚の安全性
上に問題がある等の欠点がある。この様に、炎症抑制効
果、美白効果に優れかつ皮膚安全性が高く、保存安定性
に優れた美白化粧料を得ることは困難を極めている。
【0005】本発明者らは、このような実情からみて、
従来技術の難点を改良するために鋭意研究を重ねた結
果、油溶性甘草エキスを単独で配合した場合、抗炎症作
用、抗菌作用、抗酸化作用、抗う触作用、抗プラスミン
作用およびメラニン生成抑制作用をも持つことを確認
し、他の原料にない複合的生理活性を持つことがわかっ
た。しかし、製剤に配合した場合の使用感を充分に満足
できなかった。
【0006】そこで、油溶性甘草エキスの持つ他の原料
にみられない複合的生理活性を、さらに向上させるため
研究を続けた結果、ニコチン酸アミドを併用すると相乗
的に美白効果が増強されることを見出した。
【0007】すなわち、本発明は、ニコチン酸アミドと
油溶性甘草エキスを併用して用いることにより、紫外線
吸収効果、炎症抑制効果、美白効果に優れ、かつ皮膚安
全性が高く、使用感の優れた美白化粧料を提供すること
を目的とする。
【0008】
【課題を解決するための手段】本発明者らは、上記目的
を達成するため、油溶性甘草エキスの特徴を生かしなが
ら、ニコチン酸アミドを併用することによって、美白効
果に優れ、かつ皮膚安全性が高く、使用感の優れた美白
化粧料が得られること、さらには、相乗効果によって炎
症抑制効果も一段と改善されることを見出し、本発明を
完成した。
【0009】
【発明の実施の形態】以下に、本発明の実施の形態を詳
述する。
【0010】本発明に用いる(a)ニコチン酸アミド
は、公知の薬剤で第十三改正「日本薬局方」に収載され
ている。その性状は、白色の結晶または結晶性の粉末
で、においはなく、味は苦い。また、分子量は122.
13であり、水またはエタノールに溶けやすく、エーテ
ルに溶けにくい。その本質は、末梢循環障害用薬とし
て、ペラグラ(ニコチン酸欠乏症候群、皮膚炎・光過敏
症・下痢・精神障害などの症状が現れる)の予防および
治療に用いられていたが、食生活の豊かな現代では、も
はや無用の薬剤となった。なお、本薬剤は、多くの皮膚
病薬と同様に血管拡張作用を持たない。このような状況
の中で、化粧品の分野では、ビタミンB群の一員とし
て、ニコチン酸アミドを注目している。例えば、皮膚の
柔軟剤、弱いながら皮膚炎の予防および治療剤、酸化防
止剤などに利用することが挙げられる。
【0011】本発明に用いる(b)油溶性甘草エキスは
グラブリジンなどの成分を含有する油溶性甘草エキスで
あり、特定種の甘草、すなわちGlycyrrhiza glaba Linn
e var.(通称ロシア・アフガン・トルコカンゾウ)より
抽出されたエキスに限られ、この種のみに他の原料にな
い複合的生理活性を持つことが特異的である(特開平3
−109314号公報)。なお、本エキスの抽出溶媒と
しては、中間極性の、ベンゼン、エチルエーテル、クロ
ロホルム、塩化メチレン、酢酸エチル、酢酸n−ブチ
ル、酢酸イソブチル、酢酸n−プロピルなどがある。抽
出処理する甘草を約5〜15倍量の上記溶媒に浸漬する
か、還流下に加熱する(特開平3−109314号公
報)。
【0012】本発明に用いるニコチン酸アミドの美白化
粧料への配合量は、化粧料全量中の総量として、0.0
1〜10重量%(以下、wt%と略す)である。
【0013】また、本発明に用いる油溶性甘草エキスの
美白化粧料中への配合量は、化粧品全量中の総量とし
て、蒸発残分換算で、0.001〜1.0wt%であ
る。
【0014】本発明の美白化粧料には、必須成分の他に
タール系色素、パラベンなどの防腐剤、脂肪酸セッケ
ン、セチル硫酸ナトリウムなどの陰イオン界面活性剤、
ポリオキシエチレンアルキルエーテル、ポリオキシエチ
レン脂肪酸エステル、ポリオキシエチレン多価アルコー
ル脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、
多価アルコール脂肪酸エステル、ポリグリセリン脂肪酸
エステルなどの非イオン界面活性剤、テトラアルキルア
ンモニウム塩などの陽イオン界面活性剤、ベタイン型、
スルホベタイン型、スルホアミノ酸型、N−ステアロイ
ル−L−グルタミン酸ナトリウムなどの両性界面活性
剤、レシチン、リゾフォスファチジルコリンなどの天然
系界面活性剤、ジブチルヒドロキシトルエンなどの抗酸
化剤などを、本発明の目的を損なわない範囲内で適宜配
合することができる。
【0015】本発明の美白化粧料の剤型としては、クリ
ーム、乳液、化粧水、パックなどが挙げられる。これら
は、例えば乳液等の場合、油相および水相をそれぞれ加
熱溶解したものを乳化分散して冷却する通常の方法によ
り製造することができる。また、本発明の美白化粧料
は、医薬品、医薬部外品としても適用することができ
る。
【0016】
【実施例】以下、実施例および比較例によって本発明を
詳細に説明する。なお、実施例および比較例に配合した
各成分濃度は重量%(以下、単に%と略す)である。
【0017】また、実施例で用いた油溶性甘草エキスは
溶媒を除いて得た粉末であって、グラブリジンの含有量
は、75%である。
【0018】実施例に記載の(1)皮膚色明度回復試
験、(2)美白実用試験、(3)紫外線紅斑抑制試験、
(4)光パッチ試験、(5)官能試験の各試験法は次の
通りである。
【0019】(1)皮膚色明度回復試験
被験者20名の上腕内側部皮膚(2×2cmの区画内、2
ケ 所))に紫外線照射装置(デルマレイ、N−DMR
型、東芝医療用品製)を用いてUVB領域の紫外線の最
小紅斑量を3日間連続照射して照射終了後、試料塗布部
とベース塗布部皮膚の基準明度(V0 値、V0 ’値)を
色彩色差計(CR−221型、ミノルタ製)により測定
した。引き続き、1日3回ずつ、5mg/cm2の試料とベー
スを4週間連続で塗布し、照射開始1、2、4週間後の
試料塗布部とベース塗布部皮膚の皮膚明度(Vn 値、V
n ’値)を測定して、表1の判定基準によって皮膚色の
回復評価を行った。なお、評価は被験者20名の4週間
後の評価点の平均値で示す。
【0020】
【表1】
【0021】(2)美白実用試験
被験者20名の両前腕屈側部皮膚を、夏期の太陽光に3
時間(1日1.5時間で2日間)曝露した。左前腕屈側
部皮膚には太陽光に曝された日より試料を、右前腕屈側
部皮膚には太陽光に曝された日よりベースを、5mg/cm2
の量の割合で、朝夕1回ずつ、13週連続塗布した。な
お、評価はベース塗布部より試料塗布部の効果が、顕著
に確認された被験者の人数で示す。
【0022】(3)紫外線紅斑抑制試験
除毛したハートレー系モルモット10匹の背部皮膚に、
上述と同じ紫外線照射装置を用いてUVB領域の紫外線
の最小紅斑量の2倍を2ケ 所(2×2cmの区画内)に照
射を行った。照射の24時間前と照射直後に、5mg/cm2
の量の割合で、試料およびベースを塗布し、試料塗布部
位とベース塗布部位の24時間後の紅斑の状態を、表2
の判定基準に従い評価を行った。
【0023】
【表2】
【0024】(4)光パッチ試験
被験者25名の前腕屈側部皮膚に、試料50mgを塗布し
たパッチテスト用の直径1.0cmのアルミニウム製の皿
を用いて24時間クローズドパッチテストを行った後、
夏期の太陽光に6時間(1日3時間、2日間)曝露し
た。評価は、照射24時間後に、表3の判定基準に従
い、被験者25名の皮膚の状態を評価判定した。なお、
結果は(±)以上の人数で示す。
【0025】
【表3】【0026】(5)官能試験
被験者20名を用い、顔面に試料を適量塗布し、10日
間連用した後の試料の特性を評価した。評価は、湿潤
性、親和性等のアンケート項目に対し、「皮膚に潤いが
生じた」、「皮膚への親和性が良い」、「皮膚のつやが
改善された」と回答した人数で示す。
【0027】実施例1〜4、比較例1〜3(スキンロー
ション)
表4の原料組成で、表5に記載したように有効成分を配
合して、スキンローションを調製し、前記の諸試験を実
施した。
【0028】
【表4】
【0029】
【表5】
【0030】(1)調製法
表4に記載のB成分をD成分中に、C成分をA成分中に
均一に溶解した後、A成分とD成分を均一に混合攪拌
し、次いで容器に充填して製品とした。
【0031】(2)特性
諸試験を実施した結果を表5に併せて記載する。表5に
示したように、比較例1〜3は諸試験において良好な結
果は示さなかった。一方、実施例1〜4の本発明の美白
化粧料は諸試験の総てにおいて明らかに良好な結果を示
した。また、ヒト皮膚を用いた諸試験において、試験期
間中ならびに試験終了時に皮膚刺激は認められなかっ
た。
【0032】実施例5〜8、比較例4〜6(スキンクリ
ーム)
表6の原料組成で、表7に記載したように有効成分を配
合して、スキンクリームを調製し、前記の諸試験を実施
した。
【0033】
【表6】
【0034】
【表7】
【0035】(1)調製法
表6に記載のC成分をA成分に混合し、B成分をD成分
に混合しそれぞれ均一に加熱溶解して温度を80℃にし
た。次いで、A成分中にD成分を注入乳化した後、攪拌
しながら30℃まで冷却し、次いで容器に充填して製品
とした。
【0036】(2)特性
諸試験を実施した結果を表7に併せて記載する。表7に
示したように、比較例4〜6は諸試験で良好な結果を示
さなかった。一方、実施例5〜8は諸試験の総てにおい
て明らかに良好な結果を示した。また、ヒト皮膚での諸
試験において皮膚刺激は生じなかった。
【0037】
【発明の効果】以上記載のように、本発明は紫外線吸収
作用に優れ、紫外線による皮膚の炎症抑制効果に優れ、
皮膚の色素沈着の速やかな淡色化効果、および皮膚刺激
が無い有用な使用感の優れた美白化粧料を提供すること
は明らかである。Description: BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is excellent in skin safety, has an effect of preventing skin inflammation due to ultraviolet rays, and has an effect of rapidly lightening darkened skin. Related to whitening cosmetics. More specifically, the present invention relates to a whitening cosmetic having a synergistically enhanced whitening effect by using nicotinamide and an oil-soluble licorice extract in combination, and having an effect superior to that of conventional cosmetics by containing them. [0002] Ultraviolet rays cause inflammation (erythema) of the skin and release various factors to stimulate melanocytes. As a result, the color tone changes and blackens. This darkening is due to overproduction of melanin, which is produced in melanocytes and passed to epidermal cells, and is produced by oxidation of tyrosine. Conventionally, vitamin C salts and fatty acid derivatives that prevent the oxidation of tyrosine, hydroquinone monobenzyl ether, hydrogen peroxide, A whitening cosmetic containing kojic acid or the like has been proposed. [0004] However, when kojic acid is added to these whitening cosmetics, the effect of suppressing inflammation and whitening by ultraviolet rays is not sufficiently exhibited. On the other hand, when hydroquinone monobenzyl ether or the like is blended in a whitening cosmetic, it has the effect of lightening dark-skinned skin, but has disadvantages such as a problem in skin safety. As described above, it is extremely difficult to obtain a whitening cosmetic having an excellent inflammation inhibitory effect, a whitening effect, high skin safety, and excellent storage stability. [0005] In view of such circumstances, the present inventors,
As a result of intensive studies to improve the difficulties of the prior art, when the oil-soluble licorice extract is blended alone, the anti-inflammatory, antibacterial, antioxidant, anti-tumour, antiplasmin, and melanin production inhibitory effects Was confirmed to have complex biological activity not found in other raw materials. However, the feeling of use when blended in the preparation was not sufficiently satisfied. [0006] Therefore, as a result of continuing research to further improve the complex physiological activity not found in other raw materials of the oil-soluble licorice extract, the whitening effect is synergistically enhanced when nicotinamide is used in combination. Was found. [0007] That is, the present invention, by using nicotinamide in combination with an oil-soluble licorice extract, has excellent ultraviolet absorbing effect, inflammation suppressing effect, whitening effect, high skin safety, and excellent feeling in use. The purpose is to provide whitening cosmetics. Means for Solving the Problems In order to achieve the above object, the present inventors have achieved excellent whitening effect by using nicotinamide in combination with an oil-soluble licorice extract while utilizing the characteristics of the oil-soluble licorice extract. The present inventors have found that a whitening cosmetic composition having high skin safety and excellent feeling in use can be obtained, and further, the inflammation-suppressing effect is further improved by a synergistic effect, and the present invention has been completed. Embodiments of the present invention will be described below in detail. [0010] Nicotinamide (a) used in the present invention is a known drug and is listed in the 13th revised edition of "Japan Pharmacopoeia". Its properties are white crystals or crystalline powder, no odor, and bitter taste. The molecular weight is 122.
13, easily soluble in water or ethanol, and hardly soluble in ether. It was used as a drug for peripheral circulatory disorders in the prevention and treatment of pellagra (which manifests symptoms such as nicotinic acid deficiency syndrome, dermatitis, photosensitivity, diarrhea, and psychiatric disorders). In modern times, it has become a useless drug. In addition, this drug does not have a vasodilatory effect like many skin disease drugs. Under such circumstances, in the field of cosmetics, nicotinamide has been attracting attention as a member of the vitamin B group. For example, it can be used as a softening agent for the skin, a prophylactic and therapeutic agent for dermatitis to a lesser extent, and an antioxidant. The oil-soluble licorice extract (b) used in the present invention is an oil-soluble licorice extract containing components such as glabridine, and is a specific type of licorice, that is, Glycyrrhiza glaba Linn.
e var. (commonly known as Russia, Afghan, Turkey licorice), and it is unique that this species alone has complex biological activity not found in other raw materials (Japanese Unexamined Patent Publication No.
-109314). In addition, as an extraction solvent of this extract, there are benzene, ethyl ether, chloroform, methylene chloride, ethyl acetate, n-butyl acetate, isobutyl acetate, n-propyl acetate and the like of intermediate polarity. The licorice to be subjected to the extraction treatment is immersed in about 5 to 15 times the amount of the above solvent or heated under reflux (Japanese Patent Application Laid-Open No. 3-109314). The amount of the nicotinamide used in the present invention in the whitening cosmetic is 0.0% in the total amount of the cosmetic.
1 to 10% by weight (hereinafter, abbreviated as wt%). [0013] The amount of the oil-soluble licorice extract of whitening cosmetic preparation for use in the present invention, as the total amount of the cosmetic total amount, the evaporation residue terms, 0.001~1.0Wt% der
You . [0014] The whitening cosmetic of the present invention, tar based dyes in addition to the essential ingredients, preservatives such path Raven, fatty acid soap, anionic surfactants such as sodium cetyl sulfate,
Polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene polyhydric alcohol fatty acid ester, polyoxyethylene hydrogenated castor oil,
Nonionic surfactants such as polyhydric alcohol fatty acid esters and polyglycerin fatty acid esters, cationic surfactants such as tetraalkylammonium salts, betaine type,
Sulfobetaine, sulfoamino acid type amphoteric surfactants such as N- stearoyl -L- sodium glutamate, lecithins, natural-based surfactants such as lysophosphatidylcholine, antioxidants such as dibutylhydroxytoluene and the like, It can be appropriately compounded within a range that does not impair the purpose of the present invention. [0015] Examples of the dosage form of the whitening cosmetic of the present invention include creams, emulsions, lotions, packs and the like. For example, in the case of an emulsion or the like, these can be produced by a usual method of emulsifying and dispersing a solution obtained by heating and dissolving an oil phase and an aqueous phase, respectively, followed by cooling. Further, the whitening cosmetic of the present invention can also be applied as pharmaceuticals and quasi-drugs. The present invention will be described in detail below with reference to examples and comparative examples. The concentration of each component blended in Examples and Comparative Examples is% by weight (hereinafter simply referred to as%). The oil-soluble licorice extract used in the Examples is a powder obtained by removing the solvent, and has a glabridine content of 75%. (1) Skin lightness recovery test, (2) Whitening practical test, (3) UV erythema suppression test,
The test methods of (4) optical patch test and (5) sensory test are as follows. (1) Skin color lightness recovery test The upper arm inner skin of 20 subjects (in a 2 × 2 cm section, 2
Location)) and an ultraviolet irradiation device (Dermalei, N-DMR)
After irradiating the minimum erythema amount of UVB in the UVB region for 3 days using a mold, manufactured by Toshiba Medical Supplies), the standard lightness (V0 value, V0 'value) of the sample-applied part and the base-applied part skin is colored It was measured by a color difference meter (CR-221 type, manufactured by Minolta). Subsequently, a 5 mg / cm 2 sample and a base were applied three times a day for 4 consecutive weeks, and the skin lightness (Vn value, V
n ′ value), and the skin color recovery was evaluated according to the criteria shown in Table 1. In addition, evaluation is shown by the average value of the evaluation point of 20 test subjects after 4 weeks. [Table 1] (2) Whitening Practical Test The skin on both sides of the forearm flexed by 20 subjects was exposed to sunlight in summer.
Time (1.5 hours a day for 2 days). The left forearm flexor skin had a sample from the day exposed to sunlight, and the right forearm flexor skin had a base 5 mg / cm 2 from the day exposed to sunlight.
, And applied once in the morning and evening for 13 consecutive weeks. In addition, the evaluation is shown by the number of subjects for which the effect of the sample application section was more remarkably confirmed than that of the base application section. (3) UV erythema suppression test The back skin of 10 Hartley-type guinea pigs whose hair had been removed
Using the same ultraviolet irradiation apparatus as described above, twice the minimum erythema amount of ultraviolet light in the UVB region was irradiated to two places (within a 2 × 2 cm section). 24 hours before and immediately after irradiation, 5 mg / cm 2
Table 2 shows the erythema state 24 hours after the sample and the base were applied to the sample and the base.
The evaluation was performed in accordance with the evaluation criteria. [Table 2] (4) Optical Patch Test A closed patch test was performed for 24 hours using a 1.0 cm diameter aluminum plate for patch test on which 50 mg of a sample was applied to the skin of the flexed side of the forearm of 25 subjects. ,
It was exposed to summer sunlight for 6 hours (3 hours a day, 2 days). In the evaluation, 24 hours after irradiation, the skin condition of 25 subjects was evaluated and determined according to the criteria shown in Table 3. In addition,
The results are shown by the number of people (±) or more. [Table 3] (5) Sensory Test Using 20 test subjects, an appropriate amount of the sample was applied to the face, and the characteristics of the sample after continuous application for 10 days were evaluated. The evaluation is shown by the number of respondents who answered "moisture on the skin", "good affinity for the skin", and "improved the gloss of the skin" for the questionnaire items such as wettability and affinity. Examples 1-4, Comparative Examples 1-3 (Skin Lotion) Skin lotions were prepared by mixing the active ingredients in the raw material composition shown in Table 4 as shown in Table 5, and the above tests were carried out. Carried out. [Table 4] [Table 5] (1) Preparation method After dissolving the B component and the C component uniformly in the D component and the A component in Table 4, the A component and the D component are uniformly mixed and stirred, and then filled in a container. And made it into a product. (2) The results of the various properties tests are also shown in Table 5. As shown in Table 5, Comparative Examples 1 to 3 did not show good results in various tests. On the other hand, the whitening cosmetics of the present invention of Examples 1 to 4 showed clearly good results in all tests. Further, in various tests using human skin, no skin irritation was observed during the test period and at the end of the test. Examples 5 to 8 and Comparative Examples 4 to 6 (skin cream) Skin creams were prepared by mixing the active ingredients as shown in Table 7 with the raw material compositions shown in Table 6, and the above tests were carried out. Carried out. [Table 6] [Table 7] (1) Preparation method The component C shown in Table 6 was mixed with the component A, and the component B was mixed with the component D, and each was heated and dissolved uniformly to reach a temperature of 80 ° C. Next, after injecting and emulsifying the D component in the A component, the mixture was cooled to 30 ° C. with stirring, and then filled into a container to obtain a product. (2) The results of the various properties tests are also shown in Table 7. As shown in Table 7, Comparative Examples 4 to 6 did not show good results in various tests. On the other hand, Examples 5 to 8 showed clearly good results in all of the tests. In addition, no skin irritation occurred in various tests on human skin. As described above, the present invention is excellent in an ultraviolet ray absorbing effect, is excellent in a skin inflammation suppressing effect by ultraviolet rays,
It is apparent that the present invention provides a whitening cosmetic having a rapid effect of lightening skin pigmentation and a useful feeling without skin irritation.
Claims (1)
重量%、及び(b)油溶性甘草エキスを蒸発残分換算で
0.001〜1.0重量%含有することを特徴とする美
白化粧料。(但し、尿素、紫外線吸収剤、及び紫外線散
乱剤を含有しない。)(57) [Claims] (1) (a) 0.01 to 10 nicotinamide
A whitening cosmetic comprising: (b) an oil-soluble licorice extract in an amount of 0.001 to 1.0% by weight in terms of an evaporation residue. (However, it does not contain urea, ultraviolet absorbers, and ultraviolet scattering agents.)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33754696A JP3510751B2 (en) | 1996-12-02 | 1996-12-02 | Whitening cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33754696A JP3510751B2 (en) | 1996-12-02 | 1996-12-02 | Whitening cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10158148A JPH10158148A (en) | 1998-06-16 |
| JP3510751B2 true JP3510751B2 (en) | 2004-03-29 |
Family
ID=18309676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP33754696A Expired - Fee Related JP3510751B2 (en) | 1996-12-02 | 1996-12-02 | Whitening cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3510751B2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002506804A (en) * | 1998-03-16 | 2002-03-05 | ザ、プロクター、エンド、ギャンブル、カンパニー | Skin care composition |
| JP2003012495A (en) * | 2001-07-06 | 2003-01-15 | Kanebo Ltd | Cosmetics |
| KR100530669B1 (en) * | 2002-05-21 | 2005-11-23 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Lactate and Glycyrrhiza Uralensis Extracts for Skin Whitening |
| JP4712300B2 (en) * | 2002-12-26 | 2011-06-29 | クラシエ製薬株式会社 | Whitening agent and vitamin mixture composition |
| US7357950B2 (en) * | 2003-03-21 | 2008-04-15 | Elizabeth Anne Mazzio | Topical treatment for dyshidrosis (pompholyx) and dry skin disorders |
| US7429391B2 (en) | 2004-01-30 | 2008-09-30 | Access Business Group International Llc | Holistic composition and method for reducing skin pigmentation |
| US9676696B2 (en) | 2009-01-29 | 2017-06-13 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
| FR2968661B1 (en) * | 2010-12-14 | 2016-01-01 | Oreal | PROCESS FOR DEPIGMENTING KERATINIC MATERIALS USING THIOPYRIDINONE COMPOUNDS |
| CN105434301B (en) * | 2015-03-17 | 2018-07-24 | 欧诗漫生物股份有限公司 | A kind of cleawhite over-night essences containing Margarita extract |
| CN107802559B (en) * | 2017-12-14 | 2020-09-11 | 广州市科能化妆品科研有限公司 | Whitening composition and preparation method and application thereof |
| JP7104643B2 (en) * | 2018-01-31 | 2022-07-21 | 株式会社コーセー | Aqueous composition |
-
1996
- 1996-12-02 JP JP33754696A patent/JP3510751B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10158148A (en) | 1998-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS60190708A (en) | Absorbent for ultraviolet radiation having long wavelength | |
| JP3510751B2 (en) | Whitening cosmetics | |
| JP3665360B2 (en) | Active oxygen scavenger and composition containing the same | |
| JPH04124122A (en) | Blackening agent of preventing gray hair | |
| JP2002173449A (en) | Hair-growing agent | |
| JP2001019607A (en) | Skin cosmetic | |
| JPH04346911A (en) | Cosmetic | |
| GB1588112A (en) | Preparation for the prevention and treatment of acne vulgaris | |
| JPS6360910A (en) | Skin drug for external use | |
| JPH08291039A (en) | Skin-lightening cosmetic | |
| JP3207996B2 (en) | Sunscreen cosmetics | |
| JPH11302133A (en) | Cosmetic for scalp and hair | |
| JPH0710738A (en) | Beautifying cosmetic | |
| JPH11302131A (en) | Cosmetic for scalp and hair | |
| JP2001131025A (en) | Cosmetic for scalp and hair | |
| JPH0733639A (en) | Beautifying and whitening cosmetic | |
| JPH06256140A (en) | Beautifying cosmetic | |
| JP2005200357A (en) | Hair restoration | |
| JPH0692833A (en) | Skin external agent | |
| JPH0859452A (en) | Skin cosmetics | |
| JP2003321463A (en) | Skin care preparation | |
| JPH07309738A (en) | Beautify and whitening cosmetic | |
| JP3512890B2 (en) | External preparation for preventing skin aging | |
| JPS60116616A (en) | Cosmetic | |
| JP3869949B2 (en) | Skin external preparation suitable for whitening |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20031224 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20031226 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080109 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090109 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090109 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100109 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110109 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110109 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120109 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120109 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130109 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130109 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140109 Year of fee payment: 10 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |